BTS
BMY icon

BB&T Securities’s Bristol-Myers Squibb BMY Stock Holding History

BB&T Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$30.3M Buy
598,644
+5,753
+1% +$270K 0.28% 96
2019
Q2 		$26.9M Buy
592,891
+10,765
+2% +$501K 0.24% 113
2019
Q1 		$27.8M Buy
582,126
+111,453
+24% +$5.55M 0.27% 100
2018
Q4 		$24.5M Sell
470,673
-9,805
-2% -$527K 0.27% 99
2018
Q3 		$29.8M Sell
480,478
-8,923
-2% -$530K 0.29% 91
2018
Q2 		$27.1M Sell
489,401
-88,174
-15% -$4.76M 0.29% 90
2018
Q1 		$36.5M Buy
577,575
+18,247
+3% +$1.17M 0.41% 52
2017
Q4 		$34.3M Sell
559,328
-4,678
-0.8% -$293K 0.45% 46
2017
Q3 		$35.9M Buy
564,006
+74,503
+15% +$4.35M 0.49% 37
2017
Q2 		$27.3M Sell
489,503
-299,801
-38% -$16.3M 0.4% 50
2017
Q1 		$42.9M Buy
789,304
+108,125
+16% +$5.93M 0.59% 37
2016
Q4 		$37.2M Sell
681,179
-75,776
-10% -$4.14M 0.54% 46
2016
Q3 		$40.8M Buy
756,955
+564,313
+293% +$36.2M 0.61% 38
2016
Q2 		$14.2M Buy
192,642
+9,964
+5% +$704K 0.22% 116
2016
Q1 		$11.7M Buy
182,678
+64,838
+55% +$4.09M 0.19% 123
2015
Q4 		$8.11M Buy
117,840
+22,175
+23% +$1.47M 0.17% 128
2015
Q3 		$5.66M Buy
95,665
+5,767
+6% +$366K 0.12% 154
2015
Q2 		$5.98M Buy
89,898
+4,075
+5% +$269K 0.13% 162
2015
Q1 		$5.54M Sell
85,823
-6,137
-7% -$384K 0.12% 157
2014
Q4 		$5.43M Sell
91,960
-49,079
-35% -$2.77M 0.12% 161
2014
Q3 		$7.22M Buy
141,039
+5,477
+4% +$274K 0.17% 124
2014
Q2 		$6.58M Buy
135,562
+50,384
+59% +$2.48M 0.16% 124
2014
Q1 		$4.42M Buy
85,178
+5,542
+7% +$295K 0.11% 148
2013
Q4 		$4.23M Buy
79,636
+332
+0.4% +$16.9K 0.12% 146
2013
Q3 		$3.67M Sell
79,304
-36,437
-31% -$1.6M 0.11% 135
2013
Q2 		$5.17M Buy
+115,741
New +$5.02M 0.17% 112

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BB&T Securities's BMY Position: Q3 2019 in Review

BB&T Securities increased its Bristol-Myers Squibb (BMY) stake by 0.97% in Q3 2019, buying an estimated $270K and bringing the position to 598,644 shares worth $30.3M. The position accounts for 0.28% of the portfolio, ranked #96.

BB&T Securities first reported a position in BMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $42.9M in Q1 2017. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • BB&T Securities held 598,644 shares of Bristol-Myers Squibb worth $30.3M as of Q3 2019.
  • BB&T Securities bought 5,753 Bristol-Myers Squibb shares in Q3 2019, an estimated $270K.
  • Bristol-Myers Squibb made up 0.28% of BB&T Securities's portfolio in Q3 2019, its #96 holding.
  • BB&T Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Bristol-Myers Squibb position peaked at $42.9M in Q1 2017.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.